uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
61.01
+1.68 (2.83%)
At close: Oct 24, 2025, 4:00 PM EDT
61.85
+0.84 (1.38%)
After-hours: Oct 24, 2025, 7:58 PM EDT
uniQure Employees
uniQure had 209 employees as of December 31, 2024. The number of employees decreased by 271 or -56.46% compared to the previous year.
Employees
209
Change (1Y)
-271
Growth (1Y)
-56.46%
Revenue / Employee
$68,598
Profits / Employee
-$952,129
Market Cap
3.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 209 | -271 | -56.46% |
| Dec 31, 2023 | 480 | -21 | -4.19% |
| Dec 31, 2022 | 501 | 38 | 8.21% |
| Dec 31, 2021 | 463 | 131 | 39.46% |
| Dec 31, 2020 | 332 | 84 | 33.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QURE News
- 16 days ago - uniQure: Further Upside Likely As The Opportunity Becomes Better Understood - Seeking Alpha
- 25 days ago - uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares - GlobeNewsWire
- 4 weeks ago - uniQure Announces Pricing of Upsized $300 Million Public Offering - GlobeNewsWire
- 4 weeks ago - UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street - Benzinga
- 4 weeks ago - uniQure Stock Jumps On Positive News, But Risks Remain - Benzinga
- 4 weeks ago - UniQure: How QURE Stock Rises 10x To $500? - Forbes
- 4 weeks ago - Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it - Market Watch
- 4 weeks ago - uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond - Seeking Alpha